Gene Expression Profile Tests for Early Stage Breast Cancer
Pragmatic Phase 3 Pharmaceutical Trials: Recommendations for the design of clinical trials that are more informative for patients, clinicians, and payers
Proposed Recommendations for Designing Clinical Trials for “New Indications” of Approved Oncology Drugs for Treatment of Late Stage Disease